Radio and PodcastLive Radio & PodcastsScience & Medicine
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
About This Episode
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care? is an episode from PeerVoice Clinical Pharmacology Video by PeerVoice, 11...
Podcast
This episode belongs to PeerVoice Clinical Pharmacology Video.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Feb 25, 2026, 00:19:34 long, audio available.
Related Episodes
Continue listening to more episodes from PeerVoice Clinical Pharmacology Video.
Questions About This Episode
What is Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care? about?
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
Where can I listen to Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care??
You can listen to Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care? online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care? from?
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care? is an episode from PeerVoice Clinical Pharmacology Video by PeerVoice, 1140 Avenue of the Americas, 15th Floor, New York, NY 10036.
How long is this episode?
This episode is 00:19:34 long.
When was this episode published?
This episode was published on Feb 25, 2026.
Can I save Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care? for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from PeerVoice Clinical Pharmacology Video?
Yes. This page shows related episodes from PeerVoice Clinical Pharmacology Video when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care??
You can listen to Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care? on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care? is from PeerVoice Clinical Pharmacology Video by PeerVoice, 1140 Avenue of the Americas, 15th Floor, New York, NY 10036.
What are the episode details?
Published Feb 25, 2026 and 00:19:34 long